A One-Stop Lab for Horse Diagnosis

Patent information

Equigerminal has 2 patent families that complement each other:
-
  • Viral Peptides -  WO2015094001A1 protects viral peptides for diagnosis and therapeutics purposes of the New Equine Virus (NEV).
  • Antiviral Composition - WO2016195522A2 protects a class of antivirals  to treat viral infections. 
 With 10 international patent processes and 1 biological patent deposit. 

-

 

  granted patents: 

  • Viral Peptides - EP3083659B- European Patent 🇪🇺
  • Viral Peptides - GB2526222B - United Kingdom  🇬🇧
  • Antiviral Composition - GB2544439B - United Kingdom  🇬🇧
  • Antiviral Composition - AU2017271995B  - Australia  🇦🇺